The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition.
Nature Communications
Goodwin, Justin J; Neugent, Michael L ML; Lee, Shin Yup SY; Choe, Joshua H JH; Choi, Hyunsung H; Jenkins, Dana M R DMR; Ruthenborg, Robin J RJ; Robinson, Maddox W MW; Jeong, Ji Yun JY; Wake, Masaki M; Abe, Hajime H; Takeda, Norihiko N; Endo, Hiroko H; Inoue, Masahiro M; Xuan, Zhenyu Z; Yoo, Hyuntae H; Chen, Min M; Ahn, Jung-Mo JM; Minna, John D JD; Helke, Kristi L KL; Singh, Pankaj K PK; Shackelford, David B DB; Kim, Jung-Whan JW